Corrigendum: Microfluidic-based human prostate-cancer-on-chip (Frontiers in Bioengineering and Biotechnology, (2024), 12, (1302223), 10.3389/fbioe.2024.1302223)

In the published article, there was an error in the Funding statement. The Funding statement was incorrectly written as: “The author(s) declare financial support was received for the research, authorship, and/or publication of this article. LJ, HK, ST, TC, CM, and YZ were supported by funding from NIH/NCI MPI R01 CA254200 as part of the Tissue Engineering Consortium and TACMASR by P30 CA023075 UACC support grant. TC acknowledges partial support by the NIH/NCI U54CA143924 for the Partnership of Native American Cancer Prevention (NACP).”